BRIEF-TaiwanJ Pharmaceuticals starts Phase 2 clinical study on Autoimmune Hepatitis
* Says it began JKB-122 Phase 2 clinical study on Autoimmune Hepatitis, an orphan disease, in late January and the study is expected to last for 16 weeks [Source]
Publication Date:Origin: reuters.com
Category: rbssHealthcareNews
Topics: study, clinical, Phase, weeks, is expected, January, disease, orphan, Autoimmune Hepatitis, JKB-122, began, Hepatitis, Autoimmune, starts, Pharmaceuticals, BRIEF-TaiwanJ
Source: http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/wULOgtel_mA/idUSL4N1FN0IU